AAAAAA
Results: 1-25/792
Authors:
BENAUD C
DICKSON RB
THOMPSON EW
Citation: C. Benaud et al., ROLES OF THE MATRIX METALLOPROTEINASES IN MAMMARY-GLAND DEVELOPMENT AND CANCER, Breast cancer research and treatment, 50(2), 1998, pp. 97-116
Authors:
GUNASEGARAM R
PEH KL
LOGANATH A
RATNAM SS
Citation: R. Gunasegaram et al., EXPRESSION OF 3-BETA-HYDROXYSTEROID DEHYDROGENASE-5,4-EN ISOMERASE ACTIVITY BY INFILTRATING DUCTAL HUMAN BREAST-CARCINOMA IN-VITRO, Breast cancer research and treatment, 50(2), 1998, pp. 117-123
Authors:
STIERER M
ROSEN H
WEBER R
HANAK H
AUERBACH L
SPONA J
TUCHLER H
Citation: M. Stierer et al., COMPARISON OF IMMUNOHISTOCHEMICAL AND BIOCHEMICAL MEASUREMENT OF STEROID-RECEPTORS IN PRIMARY BREAST-CANCER - EVALUATION OF DISCORDANT FINDINGS, Breast cancer research and treatment, 50(2), 1998, pp. 125-134
Authors:
HELLMANNBLUMBERG U
CARTNER MG
WURZ GT
DEGREGORIO MW
Citation: U. Hellmannblumberg et al., INTRINSIC REACTIVITY OF TAMOXIFEN AND TOREMIFENE METABOLITES WITH DNA, Breast cancer research and treatment, 50(2), 1998, pp. 135-141
Authors:
COOPER NL
BARDY P
BACANI J
KUUSK U
DOUGHERTY GJ
EAVES CJ
EMERMAN JT
Citation: Nl. Cooper et al., CORRELATION OF CD44 EXPRESSION WITH PROLIFERATIVE ACTIVITY OF NORMAL HUMAN BREAST EPITHELIAL-CELLS IN CULTURE, Breast cancer research and treatment, 50(2), 1998, pp. 143-153
Authors:
NAVARRO D
DORESTE H
CABRERA JJ
MORALES M
DIAZCHICO JC
DIAZCHICO BN
Citation: D. Navarro et al., TAMOXIFEN AZIRIDINE BINDING TO CYTOSOLIC PROTEINS FROM HUMAN BREAST SPECIMENS IS NEGATIVELY ASSOCIATED WITH ESTROGEN-RECEPTORS, PROGESTERONE RECEPTORS, PS2, AND CATHEPSIN-D, Breast cancer research and treatment, 50(2), 1998, pp. 155-166
Authors:
NIETO Y
MARTIN M
ALONSO JL
CASADO A
AYALA F
LOPEZMARTIN JA
RODRIGUEZLESCURE A
DIAZRUBIO E
Citation: Y. Nieto et al., WEEKLY CONTINUOUS-INFUSION OF 5-FLUOROURACIL WITH ORAL LEUCOVORIN IN METASTATIC BREAST-CANCER PATIENTS WITH PRIMARY RESISTANCE TO DOXORUBICIN, Breast cancer research and treatment, 50(2), 1998, pp. 167-174
Authors:
URSIN G
ROSS RK
SULLIVANHALLEY J
HANISCH R
HENDERSON B
BERNSTEIN L
Citation: G. Ursin et al., USE OF ORAL-CONTRACEPTIVES AND RISK OF BREAST-CANCER IN YOUNG-WOMEN, Breast cancer research and treatment, 50(2), 1998, pp. 175-184
Authors:
KASAMI M
VNENCAKJONES CL
MANNING S
DUPONT WD
JENSEN RA
PAGE DL
Citation: M. Kasami et al., MONOCLONALITY IN FIBROADENOMAS WITH COMPLEX HISTOLOGY AND PHYLLODAL FEATURES, Breast cancer research and treatment, 50(2), 1998, pp. 185-191
Authors:
SOYBIR G
KOKSOY F
KOYUNCU H
YALCIN O
KOSE H
TOPUZLU C
Citation: G. Soybir et al., CHEMOPREVENTION OF DMBA-INDUCED MAMMARY-GLAND CARCINOGENESIS PREVENTIVE EFFECTS OF FREE OXYGEN RADICAL SCAVENGERS, Breast cancer research and treatment, 50(2), 1998, pp. 193-199
Authors:
BENTLEY JR
DELFINO RJ
TAYLOR TH
HOWE S
ANTONCULVER H
Citation: Jr. Bentley et al., DIFFERENCES IN BREAST-CANCER STAGE AT DIAGNOSIS BETWEEN NON-HISPANIC WHITE AND HISPANIC POPULATIONS, SAN-DIEGO COUNTY 1988-1993, Breast cancer research and treatment, 50(1), 1998, pp. 1-9
Authors:
CHU LL
RUTTEMAN GR
KONG JMC
GHAHREMANI M
SCHMEING M
MISDORP W
VANGARDEREN E
PELLETIER J
Citation: Ll. Chu et al., GENOMIC ORGANIZATION OF THE CANINE P53 GENE AND ITS MUTATIONAL STATUSIN CANINE MAMMARY NEOPLASIA, Breast cancer research and treatment, 50(1), 1998, pp. 11-25
Authors:
WINGETT DG
VESTAL RE
FORCIER K
HADJOKAS N
NIELSON CP
Citation: Dg. Wingett et al., CD40 IS FUNCTIONALLY EXPRESSED ON HUMAN BREAST CARCINOMAS - VARIABLE INDUCIBILITY BY CYTOKINES AND ENHANCEMENT OF FAS-MEDIATED APOPTOSIS, Breast cancer research and treatment, 50(1), 1998, pp. 27-36
Authors:
GRUENBERGER T
GORLITZER M
SOLIMAN T
RUDAS M
MITTLBOECK M
GNANT M
REINER A
TELEKY B
SEITZ W
JAKESZ R
Citation: T. Gruenberger et al., IT IS POSSIBLE TO OMIT POSTOPERATIVE IRRADIATION IN A HIGHLY SELECTEDGROUP OF ELDERLY BREAST-CANCER PATIENTS, Breast cancer research and treatment, 50(1), 1998, pp. 37-46
Authors:
NARGESSI RD
KHABBAZ NF
XU XM
ZAMROUD M
KOLBERG J
COLLINS ML
Citation: Rd. Nargessi et al., QUANTITATION OF ESTROGEN-RECEPTOR MESSENGER-RNA IN BREAST-CARCINOMA BY BRANCHED DNA ASSAY, Breast cancer research and treatment, 50(1), 1998, pp. 47-55
Authors:
NARGESSI RD
SHIMIZU RM
XU XM
CONNOLLY J
ZAMROUD M
COLLINS ML
KOLBERG J
Citation: Rd. Nargessi et al., QUANTITATION OF PROGESTERONE-RECEPTOR MESSENGER-RNA IN BREAST-CARCINOMA BY BRANCHED DNA ASSAY, Breast cancer research and treatment, 50(1), 1998, pp. 57-62
Authors:
LU Q
YUE W
WANG JP
LIU Y
LONG B
BRODIE A
Citation: Q. Lu et al., THE EFFECTS OF AROMATASE INHIBITORS AND ANTIESTROGENS IN THE NUDE-MOUSE MODEL, Breast cancer research and treatment, 50(1), 1998, pp. 63-71
Authors:
OBERHOFF C
SZYMECZEK J
HOFFMANN O
WINKLER UH
KAISER S
SCHINDLER AE
Citation: C. Oberhoff et al., ADJUVANT ANTIESTROGEN TREATMENT WITH TAMOXIFEN IN POSTMENOPAUSAL WOMEN WITH BREAST-CANCER - A LONGITUDINAL-STUDY OF BLOOD-COAGULATION AND FIBRINOLYSIS, Breast cancer research and treatment, 50(1), 1998, pp. 73-81
Authors:
ALONSO DF
FARINA HG
SKILTON G
GABRI MR
DELORENZO MS
GOMEZ DE
Citation: Df. Alonso et al., REDUCTION OF MOUSE MAMMARY-TUMOR FORMATION AND METASTASIS BY LOVASTATIN, AN INHIBITOR OF THE MEVALONATE PATHWAY OF CHOLESTEROL-SYNTHESIS, Breast cancer research and treatment, 50(1), 1998, pp. 83-93
Authors:
STOLL BA
Citation: Ba. Stoll, WESTERN DIET, EARLY PUBERTY, AND BREAST-CANCER RISK, Breast cancer research and treatment, 49(3), 1998, pp. 187-193
Authors:
HASEBE T
TSUDA H
HIROHASHI S
SHIMOSATO Y
TSUBONO Y
YAMAMOTO H
MUKAI K
Citation: T. Hasebe et al., FIBROTIC FOCUS IN INFILTRATING DUCTAL CARCINOMA OF THE BREAST - A SIGNIFICANT HISTOPATHOLOGICAL PROGNOSTIC PARAMETER FOR PREDICTING THE LONG-TERM SURVIVAL OF THE PATIENTS, Breast cancer research and treatment, 49(3), 1998, pp. 195-208
Authors:
AMADORI D
FRASSINETI GL
DEMATTEIS A
MUSTACCHI G
SANTORO A
CARIELLO S
FERRARI M
NASCIMBEN O
NANNI O
LOMBARDI A
SCARPI E
ZOLI W
Citation: D. Amadori et al., MODULATING EFFECT OF LONIDAMINE ON RESPONSE TO DOXORUBICIN IN METASTATIC BREAST-CANCER PATIENTS - RESULTS FROM A MULTICENTER PROSPECTIVE RANDOMIZED TRIAL, Breast cancer research and treatment, 49(3), 1998, pp. 209-217
Authors:
BERNOUX A
DECREMOUX P
LAINEBIDRON C
MARTIN EC
ASSELAIN B
MAGDELENAT H
Citation: A. Bernoux et al., ESTROGEN-RECEPTOR NEGATIVE AND PROGESTERONE-RECEPTOR POSITIVE PRIMARYBREAST-CANCER - PATHOLOGICAL CHARACTERISTICS AND CLINICAL OUTCOME, Breast cancer research and treatment, 49(3), 1998, pp. 219-225
Authors:
PENOLAZZI L
LAMBERTINI E
AGUIARI G
DELSENNO L
PIVA R
Citation: L. Penolazzi et al., MODULATION OF ESTROGEN-RECEPTOR GENE-EXPRESSION IN HUMAN BREAST-CANCER CELLS - A DECOY STRATEGY WITH SPECIFIC PCR-GENERATED DNA FRAGMENTS, Breast cancer research and treatment, 49(3), 1998, pp. 227-235
Authors:
YEH KH
LIN MT
LIN DT
TANG JL
LUI LT
LIN JF
CHANG YS
CHENG AL
YU SC
CHANG KJ
CHEN YC
Citation: Kh. Yeh et al., HIGH-DOSE THERAPY WITH PERIPHERAL-BLOOD STEM-CELL (PBSC) SUPPORT USING AN INNOVATIVE MOBILIZATION REGIMEN IN PATIENTS WITH HIGH-RISK PRIMARY OR CHEMORESPONSIVE METASTATIC BREAST CANCERS, Breast cancer research and treatment, 49(3), 1998, pp. 237-244